CAS No.75498-96-3,(6r-(6-alpha,7-alpha))-7-((((2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monosodium salt Suppliers

Products Categories

Pharmaceutical (56)
Others (14)
Organic Chemicals (14)
Basic Inorganic Chemicals (2)
Reagent (1)

Basic Information

Molecular Structure:
CAS No.:	75498-96-3
Name:	(6r-(6-alpha,7-alpha))-7-((((2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monosodium salt
Article Data:	1

Formula:	C₁₆H₂₀N₇NaO₇S₃
Molecular Weight:	541.565
Synonyms:	5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[[(2-amino-2-carboxyethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,monosodium salt, [6R-[6a,7a,7(S*)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[[[(2S)-2-amino-2-carboxyethyl]thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,monosodium salt, (6R,7S)- (9CI);Cefminox sodium;Cefminox sodium salt;Meicelin;
PSA:	281.59000
LogP:	-2.14560

Synthetic route

: 52-89-1
l-cysteine hydrochloride

: 57617-09-1
7β-chloroacetamido-7α-methoxy-3-(1-methyl-1H-tetrazole-5-mercaptomethyl)-3-cephem-4-carboxylic acid

: 75498-96-3
(6R,7S)-7-[(S)-2-(2-amino-2-carboxyethylmercapto)acetamido]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

Conditions

Conditions	Yield
With ethylenediaminetetraacetic acid; sodium thiosulfate In water at 50℃; Concentration; Temperature;	97.9%

Country:
Business Type:
All

Lab/Research institutions

Trading Company

Manufacturers

Other
Certificate:
Manufacturer

Enterprise Authentication

ISO

GMP

FDA

HALAL

Display:default sort
Suppiers of more reward points first

New supplier

Total:80 Page 1 of 3 1 2 3 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 75498-96-3

Chemistry

IUPAC Name: Sodium (6R,7S)-7-[[2-(2-amino-3-hydroxy-3-oxopropyl)sulfanylacetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Systematic of Cefminox sodium (CAS NO.75498-96-3): Antibiotic MT-141 ; Meicelin ; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6R-(6-alpha,7-alpha))-
CAS NO: 75498-96-3
Classification Code: Drug / Therapeutic Agent ; Reproductive Effect
Molecular Formula of Cefminox sodium (CAS NO.75498-96-3): C₁₆H₂₀N₇NaO₇S₃
Molecular Weight: 541.5575
Molecular Structure:

H bond acceptors: 14
H bond donors: 5
Freely Rotating Bonds: 12
Polar Surface Area of Cefminox sodium (CAS NO.75498-96-3): 236.19 Å²

Uses

Cefminox sodium (CAS NO.75498-96-3) is used as cephalosporin antibiotic fungi.

Toxicity Data With Reference

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD50	intramuscular	8200mg/kg (8200mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.
mouse	LD50	intravenous	5200mg/kg (5200mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.
mouse	LD50	oral	> 10gm/kg (10000mg/kg)		Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 18, Pg. 1030, 1987.
rat	LD50	intramuscular	9600mg/kg (9600mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.
rat	LD50	intraperitoneal	8550mg/kg (8550mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.
rat	LD50	intravenous	5700mg/kg (5700mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.
rat	LD50	oral	> 15gm/kg (15000mg/kg)		Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.
rat	LD50	subcutaneous	> 15gm/kg (15000mg/kg)		Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984.